Project KYKLOS: Difference between revisions

From Halopedia, the Halo wiki

Tag: Mobile edit
mNo edit summary
Line 7: Line 7:
! Effects
! Effects
|-
|-
|Neurological Adjustments
|Neurological adjustments
|A [[Wikipedia:Cyclic adenosine monophosphate|cyclic AMP]] response element binding ([[Wikipedia:CREB|CREB]]) protein treatment, which improves information retention and spatial memory formation.
|A [[Wikipedia:Cyclic adenosine monophosphate|cyclic AMP]] response element binding ([[Wikipedia:CREB|CREB]]) protein treatment, which improves information retention and spatial memory formation.{{Ref/Reuse|HOSFMOP1}}
|-
|-
|Identity regulation
|Identity regulation
|KYKLOS biosculpting protocols to defeat facial recognition algorithms and Level-II vein-pattern bioassays.
|KYKLOS biosculpting protocols to defeat facial recognition algorithms and Level-II vein-pattern bioassays.{{Ref/Reuse|HOSFMOP1}}
|-
|-
|}
|}


==Effects==
==Side effects==
 
Following the Sequence Zero destructive testing of these augmentations, seventy percent of the subjects experienced personality fragmentation and short-term amnesia. Full genetic screening was suggested to reduce the negative side effects, as well as close monitoring following the first deployment of the project's candidates.{{Ref/Reuse|HOSFMOP1}}
Personality Fragmentation
 
Personality fragmentation and short-term amnesia was exhibited by 70% of subjects during Sequence Zero destructive testing.


==List of appearances==
==List of appearances==

Revision as of 17:20, March 19, 2022

Project: KYKLOS[1] was the codename for the series of biochemical augmentation procedures applied to ORION Project Phase 1 candidates. The project was implemented by the Colonial Administration Authority, under the supervision of Dr. Greenberg.[1]

Augmentations

Procedure Effects
Neurological adjustments A cyclic AMP response element binding (CREB) protein treatment, which improves information retention and spatial memory formation.[1]
Identity regulation KYKLOS biosculpting protocols to defeat facial recognition algorithms and Level-II vein-pattern bioassays.[1]

Side effects

Following the Sequence Zero destructive testing of these augmentations, seventy percent of the subjects experienced personality fragmentation and short-term amnesia. Full genetic screening was suggested to reduce the negative side effects, as well as close monitoring following the first deployment of the project's candidates.[1]

List of appearances

Sources

See also